Determination and prediction of P-glycoprotein and multidrug-resistance- related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography: Visual and quantitative analyses

Oncology

Volumn 70, Issue 6, 2007, Pages 403-410

  Kim, In Ju ^a   Bae, Young Tae ^a   Kim, Seong Jang ^a,b   Kim, Yong Ki ^a   Kim, Dong Soo ^a   Lee, Jung Sub ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

Author keywords

Breast cancer; MIBI; Multidrug resistance related protein; P glycoprotein; Scintimammography; Technetium 99m

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROC CURVE; TECHNETIUM TC 99M SESTAMIBI;

EID: 33847365776     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098812     Document Type: Article

References (31)

1. Simon SM, Schindler M: Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994;91:3497-3504.
2. Endicott JA, Ling V: The biochemistry of Pglycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989;58:137-171.
3. Cole SPC, Bhardwaj G, Gerlach JH, et al: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-1654.
4. Piwnica-Worms D, Chiu ML, Buddung M, et al: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.
5. Rao VV, Chiu ML, Kronauge JF, et al: Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-515.
6. Dexter D, Reddy RK, Geles KG, et al: Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clin Cancer Res 1998;4:1533-1542.
7. Filipits M, Suchomel RW, Dekan G, et al: MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res 1996;2:1231-1237.
8. Clarke R, Leonessa F, Trock B: Multidrug resistance/P-glycoprotein and breast cancer: review and metaanalysis. Semin Oncol 2005;32(suppl 7):S9-S15.
9. Trock B, Leonessa F, Clarke R: Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Can Inst 1997;89: 917-931.
10. Kostakoglu L, Ruacan S, Ergün EL, et al: Influence of the heterogeneity of P-glycoprotein expression on technetium-99m MIBI uptake in breast cancer. J Nucl Med 1998;39:1021-1026.
11. Bradshaw DM, Arceci RJ: Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol 1998;16:3674-3690.
12. Tan B, Piwnica-Worms D, Ratner L: Multidrug resistance transporters and modulation. Curr Opin Oncol 2000;12:450-458.
13. Kao CH, Tsai SC, Liu TJ, et al: P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res 2001;61:1412-1414.
14. Sun SS, Hsieh JF, Tsai SC, et al: Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results. Cancer Lett 2000;153:95-100.
15. Kostakoglu L, Elahi N, Kiratli P, et al: Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J Nucl Med 1997;38:1003-1008.
16. 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression. Int J Oncol 2002;20:1049-1055.
17. Fujii H, Nakamura K, Kubo A, et al: Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99m Tc-MIBI scintimammography. Ann Nucl Med 1998;10:307-312.
18. Yoon JH, Bom HS, Song HC, et al: Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer. Clin Nucl Med 1999;24:314-318.
19. 99mTc-sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer. Nucl Med Commun 2002;23:765-771.
20. Ciarmiello A, Del Vecchio S, Silvestro P, et al: Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 1998;16:1677-1683.
21. Cordobes MD, Starzed A, Moingeon LD, et al: Technetium-99m uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-289.
22. Del Vecchio S, Ciarmiello A, Pace L, et al: Functional retention of technetium-99m sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med 1997;38:1348-1351.
23. Geworski L, Knoop BO, Levi de Cabrejas M, et al: Recovery correction for quantification in emission tomography: a feasibility study. Eur J Nucl Med 2000;27:161-169.
24. 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system. Nucl Med Biol 2004;31:53-65.
25. Piwnica-Worms D, Rao VV, Kronauge JF, et al: Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995;34:12210-12220.
26. Liu TJ, Tsai SC, Ho YJ, et al: Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings. Cancer Invest 2002;20:199-205.
27. Liu TJ, Shiau YC, Tsai SC, et al: Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy. Breast 2003;12:58-62.
28. Ballinger JR, Bannerman J, Boxen I, et al: Technetium-99m tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996;37:1578-1582.
29. Larkin A, O'Driscoll L, Kennedy S, et al: Investigation of MRP-1 protein and MDR-1 Pglycoprotein expression in invasive breast cancer. Int J Cancer 2004;112:286-294.
30. Linn SC, Ciaccone G, van Diest PJ, et al: Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 1995;6:679-685.
31. Leonessa F, Clarke R: ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 2003;10:43-73.